Editor’s note: This is general educational information about how an initial public offering is priced between the filing of a range and the final terms. It is not investment advice. It relies on the SEC filings and FINRA rules listed at the end.
The price range printed on the cover of a preliminary prospectus is a request, not a forecast. It exists so that the offering can be marketed and so that the financial statements can be presented on some assumed basis. Between the day it is published and the night the deal prices, the underwriters run a process that is largely invisible from outside and that determines both the price and who gets the stock.
A single 2026 offering shows the whole arc, because the documents on both ends of it are public.
What the range is, and what it is assuming
Sunshine Silver Mining and Refining Company filed Amendment No. 1 to its Form S-1 on May 26, 2026. The cover stated that the company currently estimated the initial public offering price would be between $13.50 and $16.50 per share, and that the common stock had been approved for listing on the New York Stock Exchange under the symbol SSMR.
Everything else in that document is calculated off the midpoint. The prospectus assumes an initial public offering price of $15.00 per share, describes it as the midpoint of the range on the cover, and estimates net proceeds of approximately $276.6 million, or approximately $318.9 million if the underwriters exercised their option in full. It then discloses the sensitivity in both directions: a $1.00 increase or decrease in the assumed price would change net proceeds by $18.8 million, and a 1,000,000 share increase or decrease in the size of the offering would change them by $14.1 million, in each case holding the other variable constant.
That sensitivity table is what makes the assumed price legible. It states that the $15.00 figure is an assumption and gives the rate at which proceeds change with each of the two variables.
What happens between the range and the price
The activity in that window is bookbuilding, and FINRA Rule 5131 describes it by regulating it. The book-running lead manager must provide the issuer’s pricing committee, or its board where there is no pricing committee, with a regular report of indications of interest including the names of interested institutional investors and the number of shares each has indicated, together with a report of aggregate demand from retail investors. After settlement, it must provide a report of the final allocation to institutional investors including the names of purchasers and the number of shares each bought, and aggregate retail sales.
The same rule restricts what the book can be used for. Quid pro quo allocations, offering or threatening to withhold new issue shares as inducement for compensation excessive in relation to services provided, are prohibited. So is spinning, the allocation of new issue shares to accounts in which an executive officer or director of a public or covered non-public company has a beneficial interest, where the company is currently an investment banking client, where the member has been paid for investment banking services by that company in the past 12 months, where the allocation decision maker knows or has reason to know the member expects to be retained within the next 3 months, or on condition of future investment banking business. The prohibition does not reach accounts in which such persons hold in aggregate no more than 25% of the beneficial interest.
Lock-up mechanics are set in the same window. Any lock-up on transfer by officers and directors must extend to their issuer-directed shares, and at least two business days before any release or waiver, the book-running lead manager must notify the issuer and announce the impending release through a major news service.
Where the price landed, and what the aftermarket rules allow
The final prospectus priced the offering at $13.50 per share, the bottom of the range. The company sold 20,000,000 shares in a firm commitment offering for gross proceeds of $270,000,000, with underwriting discounts and commissions of $0.81 per share and $16,200,000 in total, leaving proceeds before expenses of $12.69 per share and $253,800,000. Estimated net proceeds fell to approximately $248.4 million, against the $276.6 million the amendment had shown at the midpoint. Delivery was set for on or about June 5, 2026.
The underwriters took an option to purchase a maximum of 3,000,000 additional shares to cover over-allotments, exercisable at any time within 30 days from the date of the prospectus. The prospectus states plainly that the initial public offering price was determined by negotiations between the company and the representative, and that among the factors considered were the company’s future prospects and those of its industry, its sales, earnings and other recent financial and operating information, and the ratios and market prices of comparable companies.
The stabilization language explains what the option is for. The underwriters may sell more shares than they are obligated to purchase, creating a short position. A short sale is covered if the short position is no greater than the shares available under the over-allotment option, and can be closed by exercising that option or by buying in the open market, with the choice driven by the open market price against the option price. A short position larger than the option is a naked short, which must be closed by open market purchases, and the prospectus says such a position is more likely to be created if the underwriters are concerned about downward pressure after pricing.
Analysis: pricing at the bottom of the range is a quantity decision, not just a price one
The instinct is to read a deal priced at the low end as weak demand. The filings support a more precise statement than that. The company kept the size at 20,000,000 shares and let the price fall to the floor of the range, and the disclosed sensitivities show what that choice cost. Pricing at $13.50 rather than at the $15.00 midpoint moved proceeds at the rate the amendment disclosed, $18.8 million for each $1.00 of price, while cutting the size instead would have moved them at $14.1 million per million shares.
Those two levers are the real content of the pricing night. An issuer that wants a specific dollar amount can hold the proceeds and cut the price by issuing more shares, which increases dilution. An issuer that wants to protect the share count takes the lower price. Sunshine Silver protected the share count. That is visible in the filings without any inference about investor sentiment, and it is a more defensible reading than any claim about how the book was covered, which is information the pricing committee received under Rule 5131 and the public did not.
The over-allotment option deserves the same literal reading. It is described in the prospectus as a tool for closing a short the syndicate created by selling more than it bought, and the decision between exercising it and buying in the market turns on where the stock is trading relative to the offer price. An exercised option therefore tends to indicate the stock traded above the offer price, and open market covering tends to indicate the opposite. Neither is announced as a verdict, but both are observable within the 30 day window.
What a careful reader compares, then, is not the final price against the midpoint but three pairs: the range against the price, the share count in the amendment against the share count in the final prospectus, and the estimated net proceeds in each. The gap between $276.6 million and $248.4 million is the entire negotiation, stated in the issuer’s own numbers.
